British-Swedish multinational pharmaceutical company AstraZeneca failed to meet coronavirus vaccine delivery deadlines and is now being sued by the European Union for failure to uphold their contractual agreements.
The EU, along with Brussels, decided to forgo the option to buy 100 million more doses of the coronavirus vaccine from AstraZeneca in response to their epic delivery failures, Daily Mail reports.
Ireland's Health Minister Stephen Donnelly said on Thursday that diplomats will be taking legal action against AstraZeneca for failing to deliver the contracted doses of the vaccine.
"With regard to AstraZeneca, a legal case has been initiated by the (European) Commission and earlier this week I have joined Ireland as one of the parties to that legal case, specifically around AstraZeneca's complete failure to meet its delivery and contractual agreements for April, May and June," Donnelly said to Parliament.
According to the Daily Mail, the European Union is attempting to "save face" in courts after sabotaging other countries vaccine rollouts, including Britain, for claiming vaccines were ineffective without evidence.
Only a select number of individuals in multiple different countries believe that the AstraZeneca COVID-19 is safe.
The Daily Mail reported that only one third of Germans and 23 percent of French would take the vaccine, citing safety concerns.
Since reports of safety concerns with the AstraZeneca vaccine, data indicates that the percentage of Italians and Spaniards willing to take the vaccine fell by approx. 20 percent.
Only 19 percent of citizens in the EU have received the vaccine, while the percentage of Britain’s who have taken the vaccine reached 49 percent.
The European Union became combatitive with AstraZeneca in early January after the company fell short, delivering only 30 of the 100 million they were contracted to supply.
The European Medicines Regulator (EMA) approved the AstraZeneca vaccine in January with no age limit on receiving the vaccine, but a number of EU countries refused to recommend it to people over 65. Within weeks after AstraZeneca’s approval, fear sprung out regarding the safety of the vaccine after blood clots were reported, according to the Daily Mail.
The contract between AstraZeneca and the EU indicates the company had committed to delivering 180 million vaccine doses in the second quarter. Chief Executive Pascal Soriot of AstraZeneca says he hopes to meet EU expectations on second quarter deliveries.